Cargando…

Treatment goals in IBD: A perspective from patients and their partners

OBJECTIVE: To identify and compare treatment goals between IBD patients and partners, and how these change upon receiving information. METHODS: During a patient information day a self-made survey was distributed before and after a lecture about a physicians’ view on treatments goals. Patients and pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Peek-Kuijt, Niene M.S., Aantjes, Margaretha J., Verwey, Marthe, Van Bodegom-Vos, Leti, van der Meulen-de Jong, Andrea E., Maljaars, Jeroen P.W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194327/
https://www.ncbi.nlm.nih.gov/pubmed/37213759
http://dx.doi.org/10.1016/j.pecinn.2022.100034
Descripción
Sumario:OBJECTIVE: To identify and compare treatment goals between IBD patients and partners, and how these change upon receiving information. METHODS: During a patient information day a self-made survey was distributed before and after a lecture about a physicians’ view on treatments goals. Patients and partners were asked for their preferred treatment goals at 6 weeks and at 6 months and could choose between short-term goals (symptom free, improved functioning, better QOL, normal colonoscopy) and long-term goals (prevention of surgery, complications, flares and no steroids). RESULTS: Being “symptom-free” (55.9%) was the preferred goal. Patients with higher disease activity chose more short-term goals (p=0.03) at 6 weeks. Age, gender and education did not affect treatment goals. Partners chose more short-term goals (p=0.03) at 6 weeks. Post-lecture, answers shifter to normal colonoscopy (4.2% versus 18.0%, p=0.001), and a better QOL (21.2% vs 33.3%, p=0.039) as goal at 6-months. CONCLUSIONS: Patients’ 6-week treatment goals focused on being symptom-free and having a high QOL, especially those patients with high disease activity. Partners chose more short-term goals than patients at 6 weeks. INNOVATION: General health information can be applied and translated into treatment goals. This may assist in remote shared goal setting and decision making